Immunosuppression, Generic Drugs and the FDA

Abstract

The author opines that new standards are needed for approval of generic immunosuppression. See article by Momper et al on page 1861.

Cite this work

No public copy is stored for this record, so only the metadata is cited.

Stored only when both papers are in the corpus — 47 citations exist upstream.

Papers that cite the same references — the relational fallback while embeddings are still backfilling.